|
Recurrence |
Recurrence |
Univariate |
Univariate |
Univariate |
Multivariate |
Multivariate |
Multivariate |
|
With
n = 36
|
Without
n =26
|
HR
|
95% CI
|
p
|
HR
|
95% CI
|
p
|
Age, years |
74.9±7.5 |
75.2±7.8 |
0.99 |
0.95-1.04 |
0.75 |
|
|
|
Female, n (%) |
27 (75) |
17 (65) |
1.58 |
0.74-3.37 |
0.24 |
|
|
|
Body mass index |
22.5±4.5 |
21.9±3.7 |
1.03 |
0.95-1.12 |
0.44 |
|
|
|
AF period, months |
5 (3, 14) |
9 (4, 17) |
0.99 |
0.96-1.01 |
0.32 |
|
|
|
Heart failure |
9 (25) |
2 (8) |
2.36 |
1.10-5.08 |
0.028 |
1.79 |
0.80-4.04 |
0.16 |
CHA2DS2-VASc score |
3.5±1.3 |
3.3±1.3 |
1.14 |
0.88-1.47 |
0.33 |
|
|
|
Estimated GFR, pg/ml |
56±17 |
49±19 |
1.01 |
0.994-1.03 |
0.17 |
|
|
|
Left atrial diameter, mm |
40.6±5.4 |
37.0±5.2 |
1.07 |
1.02-1.14 |
0.013 |
1.06 |
1.001-1.13 |
0.047 |
LVA size, cm2 |
16.8±11.3 |
14.1±9.6 |
1.02 |
0.99-1.05 |
0.21 |
|
|
|
LVA ablation (group B) |
17 (47) |
13 (50) |
0.95 |
0.49-1.84 |
0.89 |
0.85 |
0.44-1.66 |
0.64 |